However, the lack of specificity with CXCL9/10 with other renal pathologies, such as infection and acute kidney injury, highlight the need for multiple markers, such as exosomal mRNA, along with clinical contexts, to potentially guide clinical decisions. Here, CXCL9 is linked to acute kidney injury.